Argireline and SNAP-8 acetyl-capped sequence design

Why the acetyl cap is the first identity check

<a href="/product/cp-060">CP-060 Argireline</a> and <a href="/product/cp-062">CP-062 SNAP-8</a> are often discussed together because both are acetyl-capped cosmetic peptides derived from the SNAP-25 sequence region. For in-vitro research and cosmetic raw material formulation, the first analytical question is whether the N-terminal acetyl cap and C-terminal amide are present on the dominant species. Those two terminal features change mass, charge, chromatographic behaviour, and impurity interpretation. Canada Peptides should keep that structural question ahead of any outcome language.

Argireline is the shorter fragment, commonly represented as Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2. SNAP-8 extends the motif with two additional residues and is cataloged at Canada Peptides as an acetyl octapeptide reference lyophilizate. The verified catalog lists CP-060 at 888.9 Da and CP-062 at 1117.3 Da. That CP-062 value should be carried into the article because an earlier local article showed a different SNAP-8 mass; the catalog value is the controlling reference for this package.

SNAP-25 mimicry as a structural frame

The structural logic is based on short peptide mimicry of a protein-protein interface. SNAP-25 contributes helices to the SNARE complex, and small N-terminal fragments can be used as simplified research tools for sequence-motif studies. This does not mean the short peptide behaves like the full protein. It means the acetyl cap, acidic N-terminal residues, methionine, arginine pair, and terminal amide form a defined reference scaffold that can be verified by HPLC-MS and compared across lots.

A good research-guide article should therefore avoid vague claims and stay with measurable structure: residue count, terminal capping, methionine oxidation, charge distribution, UV absorbance, and chromatographic retention. The adjacent article on <a href="/research-guide/ghk-cu-copper-peptide-complexes">GHK-Cu copper peptide complex chemistry</a> shows a different cosmetic-standard problem, while <a href="/research-guide/palmitoylated-pentapeptide-lipidation">palmitoylated pentapeptide lipidation chemistry</a> covers the lipidated branch of the same buyer workflow.

Methionine oxidation is the load-bearing impurity line

Argireline and SNAP-8 both contain methionine. That residue is the first place to look when an impurity profile changes over storage, shipping, or sample preparation. Methionine sulfoxide adds 16 Da and can produce a shoulder peak near the main component under some reversed-phase methods. The release file should therefore quantify the oxidised species separately instead of burying it in a generic impurity total. HPLC-MS verified identity should confirm the main peak and the +16 Da variant when present.

The implication for procurement is practical. A buyer comparing two lots should ask whether the same gradient, wavelength, and integration threshold were used for both. A lot with a small, resolved methionine sulfoxide peak can still have a high main-peak purity, but it is analytically different from a lot where the shoulder is not resolved. The COA should make that difference visible. The <a href="/research-guide/reading-a-coa">COA reading guide</a> gives the broader method vocabulary.

A205, A280, and why concentration checks need context

These cosmetic peptides lack tryptophan and tyrosine, so A280 is a poor concentration check. A205 can read the peptide bond, but it is sensitive to buffer background and requires a matched blank. Amino acid analysis is more robust for absolute calibration because it reconstructs peptide content from hydrolysed residues. A reference standard article should explain those options without turning into a bench protocol.

The same principle applies to <a href="/product/cp-061">CP-061 Matrixyl</a> and <a href="/product/cp-035">CP-035 GHK-Cu</a>. Different cosmetic peptides require different secondary checks: acetylation and methionine oxidation for CP-060 and CP-062, palmitoylation yield for CP-061, and copper stoichiometry for CP-035. The common quality frame is the same: sequence or complex identity, HPLC-MS evidence, water content, residual solvents, and a formulation-relevant compatibility note.

How to read the terminal modifications on the COA

A terminal cap is not a styling detail. Loss of an acetyl group changes the mass by 42 Da. Loss or hydrolysis of a C-terminal amide changes the terminal chemistry and charge state. Those shifts are large enough to detect by mass spectrometry when the method is tuned for small peptide species. The COA should therefore report the expected mass for the modified molecule and should not rely on the product name alone to imply the cap.

The safest product-copy pattern is to spell out the structural assignment once, then use the SKU consistently. For example: CP-060 Argireline, acetyl hexapeptide reference material; CP-062 SNAP-8, acetyl octapeptide reference lyophilizate. The body can then focus on interpretation rather than repeating long sequence names. The article remains a research reference standard guide, HPLC-MS verified, and for in-vitro research use only and not for human or veterinary use.

Internal linking pattern

This article should send readers to CP-060 and CP-062 as primary PDPs, with CP-061 and CP-035 as adjacent cosmetic chemistry links. It should also point to the glossary entries for <a href="/glossary/n-terminal">N-terminal</a>, <a href="/glossary/c-terminal">C-terminal</a>, <a href="/glossary/oxidation">oxidation</a>, and <a href="/glossary/hplc-ms">HPLC-MS</a>. That structure gives search engines a clean map from sequence design to release evidence.

The reverse-index patch should add the new article to CP-060 and CP-062. It can update CP-061 and CP-035 only if the CMS team wants adjacent cosmetic standards to surface this comparison. Keeping ADD and UPDATE separate protects the orphaned-PDP objective while avoiding over-linking every cosmetic article to every cosmetic SKU.

Summary

Argireline and SNAP-8 are best compared through terminal caps, residue count, methionine oxidation, and HPLC-MS identity. The main buyer question is not which molecule is better; it is whether the vial, catalog entry, COA, and chromatogram all describe the same modified peptide species. The verified CP-062 mass in the current catalog is 1117.3 Da and should supersede older draft copy during publication review.

The article closes the orphaned-PDP gap for CP-060 and CP-062 while strengthening the cosmetic peptide cluster around Matrixyl and GHK-Cu. The language stays structural, Canadian, procurement-friendly, and explicitly limited to in-vitro research and cosmetic raw material formulation.

Release-file review checklist

For release-file review, keep the chemistry anchored to the verified SKU list: CP-060, CP-062, CP-061, CP-035. Confirm sequence or scaffold, molecular weight, HPLC-MS verified identity, counter-ion or modification state, water content, and residual-solvent method before copying the article into a production CMS. Canada Peptides should keep each inline product reference tied to the lower-case PDP route and should keep the article language limited to research reference standard selection, analytical characterisation, and procurement traceability. If a future catalog update changes a molecular weight, adds a salt form, or introduces a new related product, revise the cross-links and the patch file before publication rather than editing the claim in isolation.

Human review should verify whether the production catalog wants acetyl hexapeptide-3 or acetyl hexapeptide-8 naming for Argireline. The article uses CP-060 as the controlling SKU and avoids unsupported synonyms in the title.

Procurement traceability notes

A procurement reader should be able to move from this article to a PDP, from the PDP to a lot COA, and from the COA to a reproducible method record without guessing. That means names, SKU codes, molecular weights, and analytical terms must stay consistent across the article body, glossary, and reverse-index patch. The article should therefore be handled as a controlled content asset: update the reviewed date, check the DOI links, rerun the banned-phrase scan, and confirm the article still links to at least three product pages and two research-guide resources before publication.

Publication integration notes

This article should be slotted as the sequence-design companion to the existing cosmetic COA guide. The difference is useful for search intent. A reader who searches for Argireline or SNAP-8 structure needs residue count, terminal caps, methionine oxidation, and mass interpretation. A reader who searches for COA review needs method lines and release evidence. Linking both pages lets Canada Peptides answer both intents without duplicating copy or drifting into claims about finished products.

The main editorial risk is synonym drift. Argireline appears in market copy under more than one acetyl-hexapeptide numbering convention, and SNAP-8 mass values vary in older drafts. This package uses the verified CP-060 and CP-062 catalog records as the control source. If production later updates the catalog, revise the title, mass references, PDP links, and patch together. Do not update a single sentence and leave the reverse-index map stale. The article's value comes from consistency across SKU, article, glossary, and COA vocabulary.

CMS acceptance notes

Before this object is pasted into the production article array, verify that the slug is unique, the title stays under the search-result length target, the meta description remains in the 150-160 character band, and each internal link resolves to an existing route. Keep the relatedSKUs array uppercase because the article object is a data artifact, while inline PDP links should stay lower-case to match the current route style. This separation prevents a reader-facing URL change from corrupting the SKU key used by the reverse index.

The publication checklist should be mechanical. Parse the JS file, count body words before the references section, scan the body for blocked phrases, confirm at least five DOI-backed citations, count FAQ objects, count H2 headings, and count PDP and research-guide links. Then compare the article's SKU list with pdp_to_article_map_v3_patch.json. If the content and patch disagree, fix both in the same edit. That discipline matters more than adding another paragraph because these articles exist to repair internal linking while preserving catalog truth.

References

1. Sutton, R. B., Fasshauer, D., Jahn, R., & Brunger, A. T. (1998). Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution. Nature, 395(6700), 347–353. DOI: 10.1038/26412 2. Lintner, & Peschard. (2000). Biologically active peptides: from a laboratory bench curiosity to a functional skin care product. International Journal of Cosmetic Science, 22(3), 207–218. DOI: 10.1046/j.1467-2494.2000.00010.x 3. Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., & Whitehouse, C. M. (1989). Electrospray Ionization for Mass Spectrometry of Large Biomolecules. Science, 246(4926), 64–71. DOI: 10.1126/science.2675315 4. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985). Measurement of protein using bicinchoninic acid. Analytical Biochemistry, 150(1), 76–85. DOI: 10.1016/0003-2697(85)90442-790442-7) 5. Sigel, H., & Martin, R. B. (1982). Coordinating properties of the amide bond. Stability and structure of metal ion complexes of peptides and related ligands. Chemical Reviews, 82(4), 385–426. DOI: 10.1021/cr00050a003

Frequently asked questions

References

1. Sutton, R. B., Fasshauer, D., Jahn, R., & Brunger, A. T. (1998). Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution. Nature, 395(6700), 347–353. · link
2. Lintner, & Peschard. (2000). Biologically active peptides: from a laboratory bench curiosity to a functional skin care product. International Journal of Cosmetic Science, 22(3), 207–218. · link
3. Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., & Whitehouse, C. M. (1989). Electrospray Ionization for Mass Spectrometry of Large Biomolecules. Science, 246(4926), 64–71. · link
4. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985). Measurement of protein using bicinchoninic acid. Analytical Biochemistry, 150(1), 76–85. · link
5. Sigel, H., & Martin, R. B. (1982). Coordinating properties of the amide bond. Stability and structure of metal ion complexes of peptides and related ligands. Chemical Reviews, 82(4), 385–426. · link

References

1. Blanes‐Mira C., Clemente J., Jodas G. et al. (2002). A synthetic hexapeptide (Argireline) with antiwrinkle activity. International Journal of Cosmetic Science. · DOI
2. Katayama K., Armendariz-Borunda J., Raghow R. et al. (1993). A pentapeptide from type I procollagen promotes extracellular matrix production. Journal of Biological Chemistry. · DOI
3. Unknown author (2005). Use of a facial moisturizer containing palmitoyl pentapeptide improves the appearance of aging skin. Journal of the American Academy of Dermatology. · DOI
4. Merrifield R. (1963). Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. Journal of the American Chemical Society. · DOI
5. FIELDS G., NOBLE R. (1990). Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids. International Journal of Peptide and Protein Research. · DOI
6. Aguilar M. (n.d.). HPLC of Peptides and Proteins: Basic Theory and Methodology. HPLC of Peptides and Proteins. · DOI
7. Whitelegge J. (n.d.). HPLC and Mass Spectrometry of Intrinsic Membrane Proteins. HPLC of Peptides and Proteins. · DOI
8. Rauh M. (2012). LC–MS/MS for protein and peptide quantification in clinical chemistry. Journal of Chromatography B. · DOI